Interferon beta 1b | Radio Compass News

Bayer Healthcare Betaseron (Interferon Beta-1B) Receives Suppl Approval In U.S

09 May 2024 //

FDA

Bayer`s Biologic Betaseron (Interferon Beta 1B) Receives Approval in the U.S.

02 Sep 2022 //

FDA

Novartis Pharms`s Biological Interferon Beta-1B Receives Approval In US

02 Oct 2020 //

FDA

Bayer Healthcare Pharms`s Biological Interferon Beta-1B Receives Approval In US

01 Oct 2020 //

FDA

Novartis reports positive Phase III data for multiple sclerosis drug

03 Sep 2019 //

CLINICALTRIALSARENA

BiocurePharm, Korea Announces Closing of Private Placement

28 Feb 2019 //

PRESS RELEASE

Biocure Announces a MOU with the Government of Uzbekistan to Build a Manufacturing Plant

19 Feb 2019 //

NEWS FILE CORP

Biocure Signs a Collaboration Agreement with Y Biologics

14 Jan 2019 //

NEWS FILE CORP

Bayer Updates Betaseron (interferon beta-1b) Prescribing Information

17 Dec 2018 //

PR NEWSWIRE

Novartis` Biological Interferon Beta-1B Receives Supplemental Approval in US

12 Dec 2018 //

FDA

GSK`s Systemic Sting Agonist Could Overcome Delivery Hurdles

08 Nov 2018 //

BIOCENTURY

Bayer Healthcare Pharms` Generic Interferon Beta-1B Receives Approval in US

05 Sep 2018 //

FDA

Price cuts secure NHS place for MS drugs

14 May 2018 //

PHARMA TIMES

EMD Serono Highlights to Multiple Sclerosis Treatment with Inveg Cladribine

13 Apr 2018 //